These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

771 related items for PubMed ID: 20980091

  • 1. Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.
    Buechner J, Henriksen JR, Haug BH, Tømte E, Flaegstad T, Einvik C.
    Differentiation; 2011 Jan; 81(1):25-34. PubMed ID: 20980091
    [Abstract] [Full Text] [Related]

  • 2. MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.
    Haug BH, Henriksen JR, Buechner J, Geerts D, Tømte E, Kogner P, Martinsson T, Flægstad T, Sveinbjørnsson B, Einvik C.
    Carcinogenesis; 2011 Jul; 32(7):1005-12. PubMed ID: 21572098
    [Abstract] [Full Text] [Related]

  • 3. MYCN regulates oncogenic MicroRNAs in neuroblastoma.
    Schulte JH, Horn S, Otto T, Samans B, Heukamp LC, Eilers UC, Krause M, Astrahantseff K, Klein-Hitpass L, Buettner R, Schramm A, Christiansen H, Eilers M, Eggert A, Berwanger B.
    Int J Cancer; 2008 Feb 01; 122(3):699-704. PubMed ID: 17943719
    [Abstract] [Full Text] [Related]

  • 4. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis.
    Chen Y, Stallings RL.
    Cancer Res; 2007 Feb 01; 67(3):976-83. PubMed ID: 17283129
    [Abstract] [Full Text] [Related]

  • 5. Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma.
    Buechner J, Tømte E, Haug BH, Henriksen JR, Løkke C, Flægstad T, Einvik C.
    Br J Cancer; 2011 Jul 12; 105(2):296-303. PubMed ID: 21654684
    [Abstract] [Full Text] [Related]

  • 6. Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma.
    Henriksen JR, Haug BH, Buechner J, Tømte E, Løkke C, Flaegstad T, Einvik C.
    BMC Dev Biol; 2011 Jan 03; 11():1. PubMed ID: 21194500
    [Abstract] [Full Text] [Related]

  • 7. Exosome-like Extracellular Vesicles from MYCN-amplified Neuroblastoma Cells Contain Oncogenic miRNAs.
    Haug BH, Hald ØH, Utnes P, Roth SA, Løkke C, Flægstad T, Einvik C.
    Anticancer Res; 2015 May 03; 35(5):2521-30. PubMed ID: 25964525
    [Abstract] [Full Text] [Related]

  • 8. MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma.
    Lovén J, Zinin N, Wahlström T, Müller I, Brodin P, Fredlund E, Ribacke U, Pivarcsi A, Påhlman S, Henriksson M.
    Proc Natl Acad Sci U S A; 2010 Jan 26; 107(4):1553-8. PubMed ID: 20080637
    [Abstract] [Full Text] [Related]

  • 9. Stable knockdown of MYCN by lentivirus-based RNAi inhibits human neuroblastoma cells growth in vitro and in vivo.
    Jiang R, Xue S, Jin Z.
    Biochem Biophys Res Commun; 2011 Jul 01; 410(2):364-70. PubMed ID: 21683062
    [Abstract] [Full Text] [Related]

  • 10. A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma.
    Shohet JM, Ghosh R, Coarfa C, Ludwig A, Benham AL, Chen Z, Patterson DM, Barbieri E, Mestdagh P, Sikorski DN, Milosavljevic A, Kim ES, Gunaratne PH.
    Cancer Res; 2011 Jun 01; 71(11):3841-51. PubMed ID: 21498633
    [Abstract] [Full Text] [Related]

  • 11. A combined gene expression and functional study reveals the crosstalk between N-Myc and differentiation-inducing microRNAs in neuroblastoma cells.
    Zhao Z, Ma X, Shelton SD, Sung DC, Li M, Hernandez D, Zhang M, Losiewicz MD, Chen Y, Pertsemlidis A, Yu X, Liu Y, Du L.
    Oncotarget; 2016 Nov 29; 7(48):79372-79387. PubMed ID: 27764804
    [Abstract] [Full Text] [Related]

  • 12. Reciprocal antagonistic regulation of N-myc mRNA by miR‑17 and the neuronal-specific RNA-binding protein HuD.
    Samaraweera L, Spengler BA, Ross RA.
    Oncol Rep; 2017 Jul 29; 38(1):545-550. PubMed ID: 28560387
    [Abstract] [Full Text] [Related]

  • 13. Expression of NLRR3 orphan receptor gene is negatively regulated by MYCN and Miz-1, and its downregulation is associated with unfavorable outcome in neuroblastoma.
    Akter J, Takatori A, Hossain MS, Ozaki T, Nakazawa A, Ohira M, Suenaga Y, Nakagawara A.
    Clin Cancer Res; 2011 Nov 01; 17(21):6681-92. PubMed ID: 21908575
    [Abstract] [Full Text] [Related]

  • 14. Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs Impacts Neural Differentiation and Survival in Neuroblastoma Patients.
    Ribeiro D, Klarqvist MDR, Westermark UK, Oliynyk G, Dzieran J, Kock A, Savatier Banares C, Hertwig F, Johnsen JI, Fischer M, Kogner P, Lovén J, Arsenian Henriksson M.
    Cell Rep; 2016 Jul 26; 16(4):979-993. PubMed ID: 27396325
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1.
    Creevey L, Ryan J, Harvey H, Bray IM, Meehan M, Khan AR, Stallings RL.
    Mol Cancer; 2013 Mar 26; 12():23. PubMed ID: 23531080
    [Abstract] [Full Text] [Related]

  • 16. MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells.
    Kang JH, Rychahou PG, Ishola TA, Qiao J, Evers BM, Chung DH.
    Biochem Biophys Res Commun; 2006 Dec 08; 351(1):192-7. PubMed ID: 17055458
    [Abstract] [Full Text] [Related]

  • 17. MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas.
    Huang R, Cheung NK, Vider J, Cheung IY, Gerald WL, Tickoo SK, Holland EC, Blasberg RG.
    FASEB J; 2011 Dec 08; 25(12):4138-49. PubMed ID: 21856782
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of cyclin-dependent kinase 1-induced cell death in neuroblastoma cells through the microRNA-34a-MYCN-survivin pathway.
    Chen Y, Tsai YH, Tseng SH.
    Surgery; 2013 Jan 08; 153(1):4-16. PubMed ID: 22703967
    [Abstract] [Full Text] [Related]

  • 19. The MYCN oncogene and differentiation in neuroblastoma.
    Westermark UK, Wilhelm M, Frenzel A, Henriksson MA.
    Semin Cancer Biol; 2011 Oct 08; 21(4):256-66. PubMed ID: 21849159
    [Abstract] [Full Text] [Related]

  • 20. Expression and DNA-binding activity of MYCN/Max and Mnt/Max during induced differentiation of human neuroblastoma cells.
    Smith AG, Popov N, Imreh M, Axelson H, Henriksson M.
    J Cell Biochem; 2004 Aug 15; 92(6):1282-95. PubMed ID: 15258910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.